Supplementary Table S2 from Neoadjuvant Olaparib and Pembrolizumab Combination Therapy in the Treatment of Patients with HRD-Positive Advanced Ovarian Cancer: A Pilot Study
Authors:
- Kenichi HaranoKHKenichi Harano
- Takehiro NakaoTNTakehiro Nakao
- Shin NishioShin Nishio
- Takahiro KatsudaTKTakahiro Katsuda
- Kazuto TasakiKTKazuto Tasaki
- Kazuhiro TakeharaKTKazuhiro Takehara
- Takanori YokoyamaTYTakanori Yokoyama
- Hideki FuruyaHFHideki Furuya
- Kyoko HongoKHKyoko Hongo
- Masatoshi AsanoMAMasatoshi Asano
- Takashi IkenoTITakashi Ikeno
- Masashi WakabayashiMWMasashi Wakabayashi
Open Access
- 15 October 2026
- other
- Published by American Association for Cancer Research (AACR)